Kind of data	Data requested in the call for data	Responses from interested business operators	Comment
A. Information regarding the follow‐up of the conclusions and the recommendations for ascorbyl palmitate (E 304(i)) for all uses (EFSA ANS Panel, 2015a , b )
1. Technical data	Analytical data on current levels of arsenic, lead and mercury commercial samples of the food additive	Received	Assessed, no further follow‐up
	The lowest technologically achievable level for lead, mercury and arsenic in order to adequately define their maximum limits in the specifications	Received	Assessed, no further follow‐up
	The lowest technologically achievable level for residual solvents which can be used when manufacturing ascorbyl palmitate (E 304(i))	Received	Assessed, no further follow‐up
2. Literature searches	Literature searches from 31/9/2015 up to the date of the data submission	Received	Assessed, no further follow‐up
B. Information required for the risk assessment of ascorbyl palmitate (E 304(i)) for uses in foods for infants below 16 weeks of age
1. Technical data	Information on the levels of use of ascorbyl palmitate (E 304(i)) as well as analytical data on the concentration of ascorbyl palmitate in these foods	Received	Assessed, no further follow‐up
	Information on the fate and the reaction products of ascorbyl palmitate (E 304(i))	No specific data	Assessed, no further follow‐up
	Proposals for particular specification requirements for identity and purity of ascorbyl palmitate (E 304(i)) used in these food categories (e.g. toxic elements, solvents)	No specific data	Assessed, no further follow‐up
2. Toxicological data	Post‐marketing surveillance reports on undesired and adverse reactions, indicating the ages and other relevant data of the exposed infants and young children and the use levels in the marketed products	Received	Assessed, no further follow‐up
	Published and unpublished case reports (e.g. available nutrivigilance data) on undesired and adverse effects, associated with the oral administration of ascorbyl palmitate in any form to infants and young children	No data besides the postmarketing surveillance data	Assessed, no further follow‐up
	No other studies are required provided that the total amount of vitamin C (nutrient and food additive use) resulting from the use of ascorbyl palmitate (E 304(i) in food for infants (FC 13.1.1 and FC 13.1.5.1) does not exceed the levels of vitamin C as currently authorised in the Council Directive 2006/141/ EC	Received	Assessed, no further follow‐up
3. Literature searches	Literature searches should be conducted relevant for the safety evaluation of ascorbyl palmitate (E 304(i) when used in foods for infants below 16 weeks of age	Received	Assessed, no further follow‐up